Israeli company EarlySense Ltd. has received FDA clearance for its EverOn Touch system, which provides continuous monitoring of patients in a hospital. The new system improves on the company’s existing EverOn system with the incorporation of online alerts which inform hospital staff of patient motion. This allows for easier identification of patients with low movement, who can then be turned to reduce their risk of developing pressure ulcers.
From the press release:
The newly cleared features augment the previously FDA-approved EverOn contact-free, patient supervision system which utilizes a sensor placed underneath a hospital bed mattress. There are no leads or cuffs to connect to the patient, who has complete freedom of movement and is not burdened by any irritating attachments. The system measures patient vital signs and movements and alerts medical personnel of the changes in a patient’s condition. EverOn detects heart and respiration rates, bed entries and exits. Clinical evaluations performed worldwide with EverOn show significant improvement in clinical and economic outcomes for hospitals using the system.
Press release: EarlySense’s New EverOn® Touch System Receives FDA Clearance…
Product Page: EverOn™…
Flashback: FDA OK’s EverOn™ Monitor…